Gunter, M., Harder, S., Sascha, H., Jager, E., Al-Batran, S., Sibylle, L., Atmaca, A., Cimpoiasu, C., Neumann, A., Abera, A., Knuth, A., Kaufmann, M., Dirk, J., Alexander, B. and Maurer, W.S. (2005) Clinical Study of the Recombinant Antibody Toxin scFv(FRP5)-ETA Specific for the ErbB2/HER2 Receptor in Patients with Advanced Solid Malignomas. Breast Cancer Research, 7, R617-R626.
https://doi.org/10.1186/bcr1264

has been cited by the following article:

• TITLE: Single Chain Fragment Variables Antibody binding to EGF Receptor in the Surface of MCF7 Breast Cancer Cell Line: Application and Production Review

  AUTHORS: Elham Omer Mahgoub

  KEYWORDS: Single Chain Fragment Variable, Epidermal Growth Factor Receptor, MCF-7, Phage Display Technology

  JOURNAL NAME: Open Journal of Genetics, Vol.7 No.2, June 27, 2017

  ABSTRACT: In this review, single-chain fragment variable construction using phage-display technology as a promising anticancer immunotherapy technology is described. Cloning and the specific bio-panning selection with phage display technology, as well as the use of the epidermal growth factor receptor (EGFR) at the surface of MCF-7 cells as the antigen for the straightforward specific selection of single chain Fvs, are discussed. Moreover, phage display technologies and their application are important for vaccine production and immunotherapy against viruses and cancers. Furthermore, expression of the gene will cause the production and expression of the protein in prokaryotic and eukaryotic cells, which can be used to detect anti-cancer single chain fragment variables (scFvs). Finally, homology modelling is described to show the three-dimensional scFv structure that verifies the Complementary-Determining-Regions (CDRs) on the surface of the model.